Pravastatin Teva
HMG-CoA Reductase Inhibitor (Statin) for Cholesterol Reduction
Quick Facts About Pravastatin Teva
Key Takeaways About Pravastatin Teva
- Generic equivalent to Pravachol: Pravastatin Teva 10 mg contains the same active ingredient, in the same strength and formulation, as the original branded pravastatin, with proven bioequivalence and identical therapeutic effects
- Proven cardiovascular protection: Pravastatin significantly reduces the risk of heart attack, stroke, and cardiovascular death in patients with high cholesterol or established coronary artery disease, supported by landmark trials (WOSCOPS, CARE, LIPID)
- Fewer drug interactions: As a hydrophilic statin not metabolised by CYP3A4, pravastatin has fewer clinically significant drug interactions than lipophilic statins like simvastatin or atorvastatin, making it suitable for patients on multiple medications
- Report muscle symptoms immediately: Unexplained muscle pain, tenderness, or weakness could indicate a rare but serious side effect (rhabdomyolysis) – contact your doctor without delay
- Not safe during pregnancy: Pravastatin must not be used during pregnancy or breastfeeding as it may harm the developing foetus; effective contraception is required throughout treatment
What Is Pravastatin Teva and What Is It Used For?
Pravastatin Teva is a cholesterol-lowering medicine belonging to the statin class (HMG-CoA reductase inhibitors). It reduces the body's production of LDL (“bad”) cholesterol and increases levels of HDL (“good”) cholesterol. It is prescribed to lower the risk of heart attacks, strokes, and other cardiovascular events in patients with high cholesterol or established heart disease.
Pravastatin belongs to a group of medicines called HMG-CoA reductase inhibitors, commonly known as statins. These drugs work by blocking the enzyme HMG-CoA reductase, which plays a central role in the body's production of cholesterol in the liver. By inhibiting this enzyme, pravastatin reduces the amount of cholesterol manufactured by the liver and stimulates the liver to absorb more LDL cholesterol from the bloodstream, effectively lowering total and LDL cholesterol levels in the blood.
Cholesterol is a fatty substance that circulates in the blood. While the body needs some cholesterol for normal cell function, hormone synthesis, and bile acid production, excessive levels of LDL cholesterol can accumulate in the walls of blood vessels, forming deposits called atherosclerotic plaques. Over time, these plaques narrow and harden the arteries (a process known as atherosclerosis), restricting blood flow to vital organs. If a plaque ruptures, it can trigger a blood clot that blocks a coronary artery (causing a heart attack) or a cerebral artery (causing a stroke). Lowering LDL cholesterol with a statin slows plaque progression and stabilises existing plaques, dramatically reducing the risk of these life-threatening events.
Pravastatin Teva is indicated for the following conditions:
- Primary hypercholesterolaemia: To lower elevated total cholesterol and LDL cholesterol in patients whose levels have not responded adequately to diet and lifestyle changes alone
- Mixed dyslipidaemia: In patients with elevated cholesterol and moderately elevated triglycerides, where cholesterol reduction is the primary therapeutic goal
- Secondary prevention of cardiovascular events: In patients who have had a previous heart attack or who have unstable angina (chest pain at rest), pravastatin reduces the risk of further heart attacks, strokes, and cardiovascular death, regardless of baseline cholesterol levels
- Primary prevention of cardiovascular events: In patients with high cholesterol but no prior history of coronary artery disease, pravastatin reduces the risk of developing coronary events and heart attacks
- Post-organ transplantation: To lower elevated blood lipid levels in patients receiving immunosuppressive therapy (such as cyclosporine) following organ transplantation
When you are prescribed Pravastatin Teva, your doctor will also recommend lifestyle modifications as an essential part of your treatment. These include following a heart-healthy diet low in saturated fats and cholesterol, engaging in regular physical exercise, achieving and maintaining a healthy weight, and stopping smoking if applicable. Pravastatin works alongside these measures to provide comprehensive cardiovascular risk reduction – neither the medication nor lifestyle changes alone are as effective as the combination.
Why Is the 10 mg Strength Used?
The 10 mg tablet is typically prescribed in specific clinical situations. It is often used as a starting dose when initiating statin therapy, particularly in patients who may be sensitive to higher doses or who require only modest LDL reduction. It is also commonly prescribed for elderly patients, patients with mild to moderate kidney or liver impairment, and those with higher risk of drug interactions. In clinical trials, 10 mg pravastatin typically lowers LDL cholesterol by 15–25%, which may be sufficient for patients with mildly elevated cholesterol levels or those already close to their target LDL goal. The dose can be titrated upward to 20 mg or 40 mg based on therapeutic response and tolerability.
Pravastatin is classified as a moderate-intensity statin, typically lowering LDL cholesterol by 15–35% across its dosing range. It is one of the most well-studied statins, with large-scale clinical trials (WOSCOPS, CARE, LIPID, PROSPER) involving over 20,000 patients demonstrating significant benefits in both primary and secondary cardiovascular prevention. Pravastatin is included on the World Health Organization's Model List of Essential Medicines, reflecting its proven efficacy, safety, and cost-effectiveness for global use.
About Teva Pharmaceuticals
Teva Pharmaceutical Industries is one of the world's largest generic medicine manufacturers, headquartered in Israel with operations in over 60 countries. Generic medicines like Pravastatin Teva are required by regulators to contain the same active ingredient, at the same strength, in the same dosage form, and via the same route of administration as the reference branded product. Generic products must also demonstrate bioequivalence – meaning they release the active ingredient into the bloodstream at the same rate and to the same extent as the original. As a result, Pravastatin Teva provides the same therapeutic effect as branded pravastatin, typically at a substantially lower cost.
What Should You Know Before Taking Pravastatin Teva?
Before starting Pravastatin Teva, inform your doctor about all your medical conditions, especially liver disease, kidney disease, thyroid problems, and any history of muscle disorders. Do not use Pravastatin Teva during pregnancy or breastfeeding. Tell your doctor about all medications you are currently taking, including over-the-counter products and herbal supplements.
Contraindications
You should not take Pravastatin Teva if any of the following apply to you:
- Allergy to pravastatin sodium or any of the other ingredients in this medicine – symptoms may include rash, itching, swelling of the face or throat, or difficulty breathing
- Active liver disease or unexplained persistently elevated liver enzymes (transaminases) in blood tests – your doctor will check your liver function before starting treatment
- Pregnancy or if there is a possibility you may become pregnant – cholesterol and other products of the cholesterol synthesis pathway are essential for normal foetal development, and statins are classified as pregnancy category X
- Breastfeeding – pravastatin is excreted in breast milk and could potentially affect the nursing infant's development
- Existing liver problems that have not been fully investigated and resolved
If you are unsure whether any of these conditions apply to you, consult your doctor or pharmacist before taking Pravastatin Teva.
Warnings and Precautions
Talk to your doctor or pharmacist before taking Pravastatin Teva if you have or have had any of the following conditions:
- Kidney disease or underactive thyroid (hypothyroidism) – these conditions can increase the risk of muscle-related side effects from statins and may require dose adjustment or additional monitoring
- Alcohol problems (regular heavy drinking) – excessive alcohol consumption increases the risk of liver damage when combined with statins
- Hereditary muscle disease (in yourself or a close family member) – this may predispose you to muscle problems during statin therapy
- Previous muscle side effects from another statin or fibrate medication – you may be at higher risk of experiencing similar problems with pravastatin
- Myasthenia gravis or ocular myasthenia (diseases causing muscle weakness) – statins may occasionally worsen these conditions or trigger their onset
- Previous liver problems – your doctor will need to assess whether statin therapy is appropriate for you, and more frequent liver function monitoring may be required
- Severe respiratory impairment – inform your doctor about any significant lung conditions, as rare cases of interstitial lung disease have been reported with statins
- Current or recent use of fusidic acid (an antibiotic taken orally or by injection) within the past 7 days – the combination of fusidic acid with pravastatin can cause serious muscle damage (rhabdomyolysis)
- Age over 70 years – older patients may be more sensitive to muscle-related side effects and may require lower starting doses
If any of these conditions apply to you, your doctor may need to perform blood tests before and during treatment with Pravastatin Teva. These tests help evaluate your risk of muscle-related side effects and monitor your liver function. Additional blood tests may also be required periodically throughout treatment, particularly in the first few months or after any dose increase.
Contact your doctor immediately if you experience unexplained or persistent muscle pain, tenderness, weakness, or cramps while taking Pravastatin Teva, especially if accompanied by fever, dark urine, or general malaise. In very rare cases, these symptoms can indicate a serious condition called rhabdomyolysis, which involves severe muscle breakdown and can lead to life-threatening kidney damage. Your doctor will arrange a blood test (creatine kinase, CK) to assess the situation. Do not continue taking pravastatin if you suspect rhabdomyolysis.
During treatment with Pravastatin Teva, your doctor will also monitor you for diabetes, as statins may slightly increase the risk of developing type 2 diabetes. This risk is most relevant if you have pre-existing risk factors such as elevated fasting blood sugar, high triglycerides, overweight, or high blood pressure. However, clinical studies show that the cardiovascular benefits of statin therapy substantially outweigh the small increase in diabetes risk, particularly in patients at moderate to high cardiovascular risk.
In a small number of patients, statins can affect the liver. This is detected through routine blood tests that measure liver enzyme levels (ALT and AST). Your doctor will typically arrange liver function tests before starting treatment and periodically during therapy, especially if you develop symptoms such as unexplained fatigue, loss of appetite, or yellowing of the skin or eyes.
Use in Children and Adolescents (8–18 years)
Pravastatin may be used in children and adolescents aged 8 to 18 years with heterozygous familial hypercholesterolaemia, a hereditary condition that causes very high cholesterol levels from birth. In children before puberty, the benefits and risks of treatment should be carefully evaluated by a paediatric specialist before starting therapy. The decision to treat should take into account the child's overall cardiovascular risk profile, family history of premature cardiovascular disease, and response to dietary measures. Regular monitoring of growth, pubertal development, and cholesterol levels is essential.
Use in Elderly Patients
Elderly patients (over 65 years) can generally use pravastatin effectively. However, individuals over 70 years of age may have an increased risk of muscle-related side effects, especially if they have additional risk factors such as reduced kidney function, hypothyroidism, or take multiple medications. The 10 mg starting dose is often preferred in elderly patients, with cautious titration based on therapeutic response and tolerability.
Pregnancy and Breastfeeding
Pravastatin Teva must not be used during pregnancy. Cholesterol and other products of the cholesterol biosynthesis pathway are essential for normal foetal development, including cell membrane formation, nervous system development, and synthesis of steroid hormones. Since pravastatin inhibits cholesterol synthesis, it could potentially harm the developing foetus. If you are a woman of childbearing age, your doctor will carefully consider this before prescribing pravastatin and will explain the associated risks. Effective contraception should be used throughout treatment and for a suitable period after stopping.
If you discover that you are pregnant while taking Pravastatin Teva, stop the medication immediately and contact your doctor. While brief, inadvertent exposure during early pregnancy has not been clearly associated with birth defects in most studies, the precautionary principle applies and the medicine should be discontinued as soon as pregnancy is confirmed.
Pravastatin Teva must not be used while breastfeeding because small amounts of pravastatin are excreted in breast milk and could potentially affect the infant's development. If you need cholesterol-lowering treatment while breastfeeding, discuss alternative options with your doctor; in many cases, treatment can be deferred until after breastfeeding has concluded.
Driving and Operating Machinery
Pravastatin Teva does not usually affect your ability to drive or operate machinery. However, dizziness, blurred vision, or double vision may occasionally occur during treatment. If you experience any of these symptoms, do not drive or use machines until the effects have resolved. Always exercise caution when starting treatment or after a dose change, as individual responses to medication vary.
Important Information About Ingredients
Lactose: Pravastatin Teva tablets contain lactose (milk sugar). If you have been told by your doctor that you have an intolerance to certain sugars (such as lactose intolerance, galactose intolerance, or glucose-galactose malabsorption), contact your doctor before taking this medicine.
Sodium: This medicine contains less than 1 mmol (23 mg) sodium per tablet, meaning it is essentially “sodium-free” and is suitable for patients on a sodium-restricted diet.
How Does Pravastatin Teva Interact with Other Drugs?
Pravastatin Teva can interact with several medications, including fibrates, cyclosporine, fusidic acid, certain antibiotics, and anticoagulants. Always tell your doctor about all medications you are taking, including over-the-counter products and herbal supplements. As a hydrophilic statin, pravastatin has fewer CYP-mediated drug interactions than lipophilic statins.
Pravastatin is distinctive among statins because it is hydrophilic (water-soluble) and is not significantly metabolised by the cytochrome P450 (CYP) enzyme system, particularly CYP3A4. This means it has fewer pharmacokinetic drug interactions compared to lipophilic statins such as simvastatin, atorvastatin, and lovastatin. However, clinically important interactions can still occur, and you should inform your doctor about all medicines you are taking, both prescription and non-prescription.
Major Interactions
| Drug | Category | Effect | Recommendation |
|---|---|---|---|
| Fusidic acid (oral/IV) | Antibiotic | Combination can cause severe muscle damage (rhabdomyolysis) | Stop pravastatin during fusidic acid treatment; restart 7 days after last dose |
| Cyclosporine | Immunosuppressant | Increases pravastatin blood levels and risk of muscle toxicity | Start with 10 mg pravastatin (this strength); maximum 20 mg under close monitoring |
| Gemfibrozil / Fenofibrate | Fibrate (lipid-lowering) | Significantly increased risk of myopathy and rhabdomyolysis | Avoid combination where possible; if necessary, use lowest doses with close monitoring |
| Nicotinic acid (niacin) | Lipid-lowering | Increased risk of muscle problems when combined with statins at doses >1 g daily | Use combination cautiously; report any muscle symptoms immediately |
Moderate Interactions
| Drug | Category | Effect | Recommendation |
|---|---|---|---|
| Erythromycin / Clarithromycin / Roxithromycin | Macrolide antibiotics | May increase pravastatin levels and risk of muscle side effects | Monitor for muscle symptoms during concurrent use |
| Cholestyramine / Colestipol | Bile acid sequestrants | Reduces pravastatin absorption if taken simultaneously | Take pravastatin at least 1 hour before or 4 hours after the resin |
| Rifampicin | Antibiotic (TB treatment) | Can alter pravastatin blood levels via altered hepatic uptake | Take pravastatin at least 2 hours before rifampicin; monitor lipid response |
| Warfarin and other vitamin K antagonists | Anticoagulants | Pravastatin may enhance anticoagulant effect, altering INR values | Monitor INR closely when starting or stopping pravastatin |
| Colchicine | Anti-gout medication | Increased risk of muscle problems (myopathy) | Use combination with caution; monitor for muscle symptoms |
| Lenalidomide | Immunomodulator | Increased risk of muscle problems when combined with statins | Monitor for muscle symptoms during concurrent use |
Interactions with Food, Drink and Herbal Products
Pravastatin Teva can be taken with or without food – meals do not significantly affect its absorption or efficacy. Unlike some other statins (such as simvastatin and lovastatin), pravastatin does not interact significantly with grapefruit juice because it is not metabolised by CYP3A4. However, if you regularly consume large amounts of alcohol, inform your doctor, as excessive alcohol intake combined with statin therapy increases the risk of liver damage. Some herbal products, particularly St John's Wort and red yeast rice (which contains a natural statin called monacolin K), should be avoided as they may affect how pravastatin works or duplicate its effects.
What Is the Correct Dosage of Pravastatin Teva?
The Pravastatin Teva 10 mg tablet is often used as a starting dose or for maintenance therapy. The usual adult dose range for pravastatin is 10–40 mg once daily, preferably taken in the evening. Your doctor will determine the correct dose for you based on your cholesterol levels, cardiovascular risk, and overall health. Always take this medicine exactly as prescribed.
Always take Pravastatin Teva exactly as your doctor or pharmacist has told you. Do not change your dose without consulting your doctor first. The tablet should be swallowed with half a glass of water and can be taken with or without food. The 10 mg tablet is typically not scored and should be swallowed whole. If you require a different dose, your doctor may prescribe a different strength rather than having you split the tablet.
Adults
Standard Dosing (Primary Hypercholesterolaemia)
Starting dose: 10–40 mg once daily, preferably in the evening
Maximum dose: 40 mg once daily
Most patients are started on 10 or 20 mg and the dose is adjusted after 4 weeks based on blood lipid response. The 10 mg tablet (Pravastatin Teva) is often used for initial treatment in patients with mildly elevated cholesterol, elderly patients, or those with additional risk factors for statin intolerance. Taking pravastatin in the evening is recommended because the liver produces the most cholesterol during the night, and evening dosing maximises the drug's effectiveness.
Secondary Prevention (After Heart Attack or Unstable Angina)
Usual dose: 40 mg once daily
If you have had a heart attack or experience chest pain at rest (unstable angina), your doctor will typically prescribe the higher 40 mg dose to maximise cardiovascular protection, regardless of your current cholesterol levels. Patients may be started on 10 mg and titrated upward if they experience tolerability issues.
Children and Adolescents (8–18 years)
Heterozygous Familial Hypercholesterolaemia Only
Ages 8–13 years: 10–20 mg once daily
Ages 14–18 years: 10–40 mg once daily
Use in children is restricted to those with an inherited condition causing very high cholesterol levels from birth and should be supervised by a specialist doctor experienced in managing paediatric lipid disorders. The 10 mg tablet is the preferred starting strength for children.
Elderly Patients
Patients Over 70 Years
Starting dose: 10 mg once daily
Elderly patients often benefit from starting at the lower 10 mg dose due to increased sensitivity to muscle-related side effects and the possibility of reduced kidney function. Dose increases should be made cautiously based on therapeutic response and tolerability. Regular follow-up with blood tests to monitor liver enzymes and creatine kinase is advisable.
Patients with Kidney or Liver Impairment
Reduced Kidney or Liver Function
Starting dose: 10 mg once daily
Patients with reduced kidney or liver function should begin treatment at the lower 10 mg dose. Your doctor will determine whether dose increases are appropriate based on your response and tolerability. Severe hepatic impairment is a contraindication to pravastatin therapy, while patients with mild-to-moderate renal impairment generally tolerate treatment well.
Organ Transplant Recipients
Post-Transplant Lipid Management
Starting dose: 10–20 mg once daily (maximum 20 mg)
If you are taking immunosuppressive medicines such as cyclosporine following an organ transplant, your doctor will start you on a low dose of 10–20 mg daily. The 10 mg strength is particularly appropriate given the increased pravastatin levels that occur with concurrent cyclosporine use. Regular monitoring of lipid levels, muscle symptoms, and kidney function is essential.
Timing with Bile Acid Sequestrants
If you also take a cholesterol-lowering resin such as cholestyramine or colestipol, you should take Pravastatin Teva at least 1 hour before or 4 hours after the resin. This is because the resin can bind to pravastatin in the gastrointestinal tract and significantly reduce its absorption if taken too close together, potentially compromising its cholesterol-lowering effect.
Duration of Treatment
Your doctor will tell you how long to continue taking Pravastatin Teva. This medication is typically prescribed for long-term use – often for many years or indefinitely – as its cardiovascular protective benefits depend on sustained treatment. Do not stop taking the medication without your doctor's approval, even if you feel well, as high cholesterol usually has no symptoms. Stopping treatment abruptly may cause a rebound rise in LDL cholesterol and loss of cardiovascular protection within weeks.
Missed Dose
If you forget to take a dose, take it as soon as you remember, unless it is nearly time for your next dose. In that case, simply skip the missed dose and take your next dose at the usual time. Do not take a double dose to make up for the one you missed. If you frequently forget doses, consider setting a daily reminder on your phone or using a pill organiser.
Overdose
If you have taken more Pravastatin Teva than prescribed, or if a child has accidentally ingested the medication, contact your doctor, hospital emergency department, or poison control centre immediately for risk assessment and advice. There is no specific antidote for pravastatin overdose. Treatment is supportive, and your doctor will monitor you for any adverse effects. Acute overdose symptoms are typically mild, but blood tests for liver enzymes and creatine kinase may be performed to check for tissue injury.
What Are the Side Effects of Pravastatin Teva?
Like all medicines, Pravastatin Teva can cause side effects, although not everybody gets them. The most commonly reported side effects include dizziness, headache, digestive disturbances, and muscle or joint pain. Rarely, serious muscle damage (rhabdomyolysis) can occur. Report any unexplained muscle symptoms to your doctor immediately.
Most side effects of pravastatin are mild and may improve as your body adjusts to the medication. The 10 mg dose is generally the best-tolerated pravastatin strength, with lower rates of muscle-related side effects than higher doses. However, some side effects require immediate medical attention. If any side effect becomes severe or persistent, consult your doctor or pharmacist.
- Swelling of the face, lips, mouth, tongue, eyes, or throat; difficulty swallowing; hives; or difficulty breathing – these are symptoms of a serious allergic reaction (angioedema, anaphylaxis)
- Unexplained or persistent muscle pain, tenderness, weakness, or cramps, especially if accompanied by fever, dark-coloured urine, or general malaise – this could indicate rhabdomyolysis, a very rare but potentially life-threatening condition
- Yellowing of the skin or whites of the eyes (jaundice), loss of appetite, feeling generally unwell, or abdominal pain – these may indicate serious liver or pancreatic inflammation
- Severe skin reactions including blistering, peeling, or widespread rash (Stevens-Johnson syndrome is extremely rare but possible)
Uncommon
May affect up to 1 in 100 people
- Dizziness, headache
- Sleep disturbances, insomnia
- Visual disturbances (blurred vision, double vision)
- Digestive problems: heartburn, abdominal pain or discomfort, nausea, vomiting, diarrhoea, constipation, flatulence
- Skin reactions: rash, itching, urticaria (hives), scalp or hair changes including hair loss
- Urination changes (difficulty emptying the bladder, frequent urination, nighttime urinary urgency)
- Sexual dysfunction
- Fatigue
- Muscle and joint pain
- Tendon inflammation, which may in rare cases progress to tendon rupture
Rare
May affect up to 1 in 1,000 people
- Increased skin sensitivity to sunlight (photosensitivity)
Very Rare
May affect up to 1 in 10,000 people
- Tingling or numbness in the hands and feet (peripheral neuropathy)
- Allergic condition with joint pain, rash, and fever (lupus erythematosus-like syndrome)
- Muscle pain or weakness (myopathy), muscle inflammation (myositis or polymyositis)
- Rhabdomyolysis (severe muscle breakdown) with or without acute kidney injury
- Abnormal liver blood tests: increased transaminase levels
- Fulminant hepatic necrosis (very rarely)
- Skin and muscle inflammation (dermatomyositis)
Frequency Not Known
Cannot be estimated from available data
- Persistent muscle weakness (immune-mediated necrotising myopathy)
- Lichenoid skin rash
- Myasthenia gravis (disease causing generalised muscle weakness, sometimes including breathing muscles)
- Ocular myasthenia (muscle weakness affecting the eyes)
- Muscle or tendon rupture
If you experience weakness in your arms or legs that worsens after periods of activity, double vision or drooping eyelids, difficulty swallowing, or shortness of breath, contact your doctor as these may indicate myasthenia gravis – a rare but reportable adverse effect of statins.
Side Effects Reported with Statins as a Class
The following side effects have been reported with some statins and may potentially occur with Pravastatin Teva:
- Nightmares and vivid dreams – thought to be less common with pravastatin than with lipophilic statins due to its limited penetration of the blood-brain barrier
- Memory loss or confusion – usually mild and reversible upon discontinuation
- Depression – rare but reported; report persistent mood changes to your doctor
- Breathing difficulties including persistent cough, shortness of breath, or fever (possible interstitial lung disease – very rare)
- New-onset type 2 diabetes – more likely if you have elevated blood sugar, high triglycerides, overweight, or high blood pressure; your doctor will monitor you during treatment
The incidence of these class effects is generally lower with pravastatin than with some other statins, particularly for central nervous system effects, due to pravastatin's hydrophilic nature. If you experience any side effects not listed here, or if any side effect becomes severe, contact your doctor or pharmacist. Reporting suspected side effects helps ensure ongoing monitoring of the medicine's benefit-risk balance.
How Should You Store Pravastatin Teva?
Store Pravastatin Teva tablets in their original packaging at room temperature (below 25°C), protected from moisture and light. Keep out of the reach and sight of children. Do not use after the expiry date printed on the carton and blister.
Keep Pravastatin Teva in its original blister packaging to protect the tablets from moisture and light, as the active ingredient is moisture-sensitive. Check the expiry date (marked “EXP” on the carton and blister) before taking any tablets. The expiry date refers to the last day of the stated month.
Store the tablets below 25°C. Do not store in the bathroom or kitchen where temperature and humidity can fluctuate significantly. A bedroom drawer or a dedicated medicine cupboard is preferable.
Keep this medicine out of the sight and reach of children. Accidental ingestion of pravastatin by a child is unlikely to cause serious harm but warrants prompt medical evaluation.
Do not flush unused tablets down the toilet or dispose of them in household waste. Return any unused or expired medication to your local pharmacy for safe disposal. Proper medication disposal protects the environment from pharmaceutical contamination of water systems and soil.
What Does Pravastatin Teva Contain?
Each Pravastatin Teva 10 mg tablet contains 10 mg of pravastatin sodium as the active ingredient, along with inactive ingredients including microcrystalline cellulose, lactose monohydrate, and various excipients that ensure proper tablet formation and stability.
Active Ingredient
The active substance is pravastatin sodium. Each 10 mg tablet contains 10 mg of pravastatin sodium. Pravastatin works by inhibiting HMG-CoA reductase, the enzyme responsible for cholesterol synthesis in the liver.
Inactive Ingredients (Excipients)
The other ingredients are: microcrystalline cellulose, lactose monohydrate, anhydrous disodium phosphate, croscarmellose sodium, sodium lauryl sulfate, povidone K25, colloidal anhydrous silica, and magnesium stearate. These are standard pharmaceutical excipients used to ensure proper tablet formation, stability, and disintegration in the digestive tract. The specific excipient list may vary slightly between manufacturing batches; always refer to the package leaflet included with your medication for the most accurate and current information.
Tablet Appearance and Packaging
10 mg tablets: Small round or oval tablets, typically yellow or pale yellow, without a score line. The exact visual characteristics may vary – always check your medication matches the description in the package leaflet.
Pravastatin Teva is supplied in aluminium/aluminium blister packs of various sizes. Common pack sizes include 7, 14, 28, 30, 50, 60, 90, 98, and 100 tablets. Not all pack sizes may be marketed in your country; your pharmacist will supply the pack size appropriate for your prescription.
Manufacturer
Marketing authorisation holder: Teva Pharmaceuticals. Teva is one of the world's largest generic pharmaceutical companies, headquartered in Petah Tikva, Israel, with manufacturing and distribution operations in over 60 countries. Teva's generic medicines, including Pravastatin Teva, are produced according to Good Manufacturing Practice (GMP) standards and are subject to the same regulatory oversight as branded pharmaceutical products.
How Does Pravastatin Work in the Body?
Pravastatin works by competitively inhibiting HMG-CoA reductase, the rate-limiting enzyme in cholesterol synthesis. This reduces hepatic cholesterol production, causing the liver to upregulate LDL receptors on its surface, which increases LDL cholesterol clearance from the blood. Pravastatin is unique among statins for its hydrophilic nature, which contributes to its favourable drug interaction profile and relatively liver-selective action.
The body produces cholesterol primarily in the liver through a complex biochemical pathway involving approximately 30 enzymatic steps. The key rate-limiting step in this pathway is the conversion of HMG-CoA (3-hydroxy-3-methylglutaryl-coenzyme A) to mevalonate, catalysed by the enzyme HMG-CoA reductase. Pravastatin is a structural analogue of HMG-CoA and competitively binds to the active site of this enzyme, blocking its activity and reducing the rate of cholesterol production by the liver cells (hepatocytes).
When intrahepatic cholesterol levels fall, the liver compensates by increasing the number of LDL receptors on its cell surface through a feedback mechanism mediated by the transcription factor SREBP-2 (sterol regulatory element-binding protein 2). These receptors capture LDL cholesterol particles circulating in the blood, drawing them into the liver for metabolism and excretion via bile. The net result is a significant reduction in both total cholesterol and LDL cholesterol in the bloodstream. Pravastatin also moderately reduces triglyceride levels and modestly increases HDL cholesterol (the “good” cholesterol that helps remove cholesterol from artery walls and transport it back to the liver for elimination).
Expected Cholesterol Reduction with 10 mg
Clinical studies have shown that the 10 mg pravastatin dose typically produces the following changes in blood lipid levels after 4–8 weeks of treatment:
- LDL cholesterol: reduction of approximately 15–22%
- Total cholesterol: reduction of approximately 12–18%
- Triglycerides: reduction of approximately 7–15%
- HDL cholesterol: increase of approximately 3–7%
Individual responses vary, and your doctor may titrate the dose upward to 20 or 40 mg if the 10 mg dose does not achieve your target lipid levels.
Hydrophilic Properties
Pravastatin is distinctly hydrophilic (water-soluble), in contrast to most other statins which are lipophilic (fat-soluble). This hydrophilicity means that pravastatin does not freely cross cell membranes into non-hepatic tissues. Instead, it is actively transported into the liver by organic anion transporting polypeptides (OATP1B1 and OATP2B1). This liver-selective action is thought to contribute to a lower incidence of muscle-related side effects compared to some lipophilic statins, particularly at comparable therapeutic doses. It also means that pravastatin is not significantly metabolised by the CYP3A4 enzyme system, resulting in far fewer pharmacokinetic drug interactions. Furthermore, limited penetration of the blood-brain barrier may explain the lower reported incidence of central nervous system effects such as nightmares and cognitive disturbances with pravastatin.
Pharmacokinetic Profile
After oral administration, pravastatin is rapidly absorbed from the gastrointestinal tract. Peak plasma concentrations are reached approximately 1–1.5 hours after dosing. The oral bioavailability is approximately 17%, reflecting extensive first-pass extraction by the liver, which is the intended site of action. Food intake modestly decreases bioavailability by about 30% but does not significantly affect cholesterol-lowering efficacy, meaning pravastatin can be taken with or without meals.
The elimination half-life is 1.5–2 hours, which is shorter than many other statins. Despite this short half-life, pravastatin remains clinically effective with once-daily dosing because its primary action occurs within the liver, where it persistently reduces cholesterol synthesis even after plasma levels have declined. Approximately 70% of the absorbed dose is eliminated via the faeces (through bile), with about 20% excreted by the kidneys. Pravastatin is approximately 50% protein-bound in the blood, considerably less than lipophilic statins (which are typically >95% protein-bound). This low protein binding further contributes to its favourable drug interaction profile.
Evidence from Clinical Trials
Pravastatin's cardiovascular benefits have been documented in several landmark trials:
- WOSCOPS (West of Scotland Coronary Prevention Study) – demonstrated that pravastatin 40 mg daily reduced the risk of coronary events by 31% in men with high cholesterol but no prior heart disease
- CARE (Cholesterol and Recurrent Events) – showed that pravastatin reduced recurrent coronary events by 24% in patients with previous myocardial infarction and average cholesterol levels
- LIPID (Long-term Intervention with Pravastatin in Ischaemic Disease) – found a 24% reduction in coronary mortality with pravastatin in patients with coronary heart disease
- PROSPER (Prospective Study of Pravastatin in the Elderly at Risk) – confirmed cardiovascular benefits in elderly patients, with a 15% reduction in the primary composite endpoint
Frequently Asked Questions About Pravastatin Teva
Pravastatin Teva is used to lower elevated cholesterol levels and reduce the risk of cardiovascular events such as heart attacks and strokes. It is prescribed for patients with primary hypercholesterolaemia, for secondary prevention in patients with existing heart disease or previous heart attack, and for managing elevated lipids in organ transplant recipients. The 10 mg tablet is often used as a starting dose or for maintenance therapy in patients requiring modest LDL reduction.
Yes. Pravastatin Teva is a generic pravastatin manufactured by Teva Pharmaceuticals and is therapeutically equivalent to other brands of pravastatin (such as Pravachol, Pravastatin Sandoz, or Pravastatin Krka). All generic pravastatin products must demonstrate bioequivalence to the original branded product, meaning they deliver the same amount of active ingredient into the bloodstream at the same rate. Generic medicines are required to meet the same quality, safety, and efficacy standards as branded products, usually at a substantially lower cost.
The most commonly reported side effects of pravastatin are classified as uncommon (affecting up to 1 in 100 people) and include dizziness, headache, sleep disturbances, visual disturbances (blurred or double vision), digestive problems (heartburn, abdominal pain, nausea, diarrhoea, constipation, flatulence), skin reactions (rash, itching, hives), urination changes, fatigue, and muscle or joint pain. Most side effects are mild and may improve over time as your body adjusts to the medicine. The 10 mg dose is generally the best-tolerated pravastatin strength.
Pravastatin Teva should be taken once daily, preferably in the evening, with half a glass of water. It can be taken with or without food. Evening dosing is recommended because cholesterol production in the liver is highest during the night, making the drug most effective when taken at bedtime. Take it at the same time each day for a consistent effect. Unlike some other statins, pravastatin does not interact with grapefruit juice and has no significant food-drug interactions.
No. Pravastatin Teva must not be used during pregnancy or breastfeeding. Cholesterol and related compounds are essential for normal foetal development, and inhibiting their production could potentially harm the baby. If you are pregnant or planning to become pregnant, inform your doctor immediately so that cholesterol-lowering treatment can be paused or alternatives considered. If you discover you are pregnant while taking pravastatin, stop the medication right away and contact your doctor. Effective contraception is required throughout treatment.
Contact your doctor without delay if you experience unexplained or persistent muscle pain, tenderness, weakness, or cramps, particularly if accompanied by fever, dark-coloured urine, or general malaise. In very rare cases, statins can cause rhabdomyolysis – a serious condition involving severe muscle breakdown that can lead to acute kidney injury. Your doctor will perform a blood test to measure creatine kinase (CK) levels and determine whether you should continue, reduce the dose, or stop taking the medication. Muscle symptoms are less common with the 10 mg dose than with higher pravastatin doses.
Pravastatin is a hydrophilic (water-soluble) statin, which sets it apart from lipophilic statins like simvastatin and atorvastatin. Because it is not significantly metabolised by the CYP3A4 enzyme system, pravastatin has fewer clinically important drug interactions – notably, it does not interact with grapefruit juice. This makes it a particularly suitable choice for patients taking multiple medications or for elderly patients. Pravastatin is considered a moderate-intensity statin, typically lowering LDL cholesterol by 15–35%, compared to the 40–60% achieved by high-intensity statins like atorvastatin or rosuvastatin.
In most cases, statin therapy is intended as long-term treatment, often lifelong. The cardiovascular benefits of pravastatin – reducing the risk of heart attack, stroke, and cardiovascular death – depend on sustained LDL cholesterol reduction. Stopping treatment usually causes cholesterol levels to rise back to pre-treatment values within a few weeks, and the protective effect is lost. Your doctor may adjust the dose or consider discontinuation in certain circumstances, such as severe side effects or a dramatic change in your cardiovascular risk profile, but you should never stop taking pravastatin without first discussing it with your doctor.
References
This article is based on the following international medical guidelines and peer-reviewed sources. All medical claims have evidence level 1A, the highest quality of evidence based on systematic reviews of randomised controlled trials.
- Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. European Heart Journal. 2020;41(1):111–188. doi:10.1093/eurheartj/ehz455
- Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol. Journal of the American College of Cardiology. 2019;73(24):e285–e350. doi:10.1016/j.jacc.2018.11.003
- Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia (WOSCOPS). New England Journal of Medicine. 1995;333(20):1301–1307. doi:10.1056/NEJM199511163332001
- Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels (CARE). New England Journal of Medicine. 1996;335(14):1001–1009. doi:10.1056/NEJM199610033351401
- The LIPID Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels (LIPID). New England Journal of Medicine. 1998;339(19):1349–1357. doi:10.1056/NEJM199811053391902
- Shepherd J, Blauw GJ, Murphy MB, et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. The Lancet. 2002;360(9346):1623–1630. doi:10.1016/S0140-6736(02)11600-X
- National Institute for Health and Care Excellence (NICE). Cardiovascular disease: risk assessment and reduction, including lipid modification. NICE guideline [CG181]. Updated 2023.
- World Health Organization (WHO). WHO Model List of Essential Medicines – 23rd list. Geneva: WHO; 2023.
- European Medicines Agency (EMA). Pravastatin – Summary of Product Characteristics. EMA product information database. Accessed February 2026.
- British National Formulary (BNF). Pravastatin sodium. NICE BNF monograph. Accessed February 2026.
- U.S. Food and Drug Administration (FDA). Pravastatin sodium tablets – prescribing information. FDA Drugs@FDA database. Accessed February 2026.
Editorial Team
This article has been written and reviewed by the iMedic Medical Editorial Team, a group of licensed specialist physicians with expertise in cardiology, clinical pharmacology, and internal medicine.
Medical Writers
Board-certified physicians specialising in cardiovascular medicine and clinical pharmacology with documented academic and clinical experience.
Medical Reviewers
Independent review board ensuring clinical accuracy, adherence to international guidelines (ESC, AHA, NICE, WHO), and evidence level 1A standards.
All content follows the GRADE evidence framework and is reviewed against current international guidelines. We have no commercial funding or pharmaceutical sponsorship. For more information, see our editorial standards and medical team pages.